Which patient is going to benefit from surgical cytoreduction with intraperitoneal chemotherapy (for manifest peritoneal metastases)?

Publié en ligne: 09 mars 2018

Pages: 207 - 210

Reçu: 18 déc. 2017

Accepté: 29 déc. 2017

DOI: https://doi.org/10.1515/cipms-2017-0040

Mots clés

peritoneal neoplasms, hyperthermia, induced, stomach neoplasms, cytoreduction surgical procedures, induction chemotherapy, laparoscopy

© 2017 Sebastian Blaj et al., published by De Gruyter Open

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.